CCT3 and hepatocellular carcinoma: Additionally, to further investigate the impact of CCT3 on the susceptibility of HCC to Sorafenib, two small interfering RNA (siRNA) sequences targeting CCT3 were designed and utilized to suppress CCT3 expression in two HCC cell lines, namely 97 L and LM3.